Vote Scores

Home / Companies / Opus Genetics, Inc. / 30 Apr 2025

Meeting · year to 30 June 202533 filers reporting

Opus Genetics, Inc.: meeting of 30 Apr 2025

Votes reported on Form N-PX, item by item

33 Form N-PX filers reported votes at the Opus Genetics, Inc. meeting of 30 Apr 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

9 nominees; 91.7% of reported votes for; one filer withheld from or voted against at least one nominee.

108 vote records from 7 filers. 1 of the 7 filers that marked the item either way voted against management.

85.7% for0.0% against14.3% other14.3% against management7 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

43 vote records from 33 filers. 9 of the 31 filers that marked the item either way voted against management. 2 filers reported this item without a management mark.

66.7% for24.2% against9.1% other29.0% against management33 filers91.4% for8.3% against0.3% other8.6% against management16,779,046 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

12 vote records from 7 filers. 1 of the 7 filers that marked the item either way voted against management.

85.7% for0.0% against14.3% other14.3% against management7 filers98.4% for0.0% against1.6% other1.6% against management2,645,634 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

12 vote records from 7 filers. 1 of the 7 filers that marked the item either way voted against management.

85.7% for0.0% against14.3% other14.3% against management7 filers98.4% for0.0% against1.6% other1.6% against management2,645,634 reported shares, counted once per item in this group
5

CORPORATE GOVERNANCEIssuer

CORPORATE GOVERNANCE: management items

Management items in this category are shown together; filers word and number them differently.

12 vote records from 7 filers. 1 of the 7 filers that marked the item either way voted against management.

85.7% for0.0% against14.3% other14.3% against management7 filers98.4% for0.0% against1.6% other1.6% against management2,645,634 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesForForFor
FidelityForForFor
State Street and SPDRNo reportForNo report
EquitableForForFor
Northern Trust and FlexSharesNo reportForNo report
BNY MellonNo reportForNo report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the Opus Genetics, Inc. meeting?

33 Form N-PX filers reported votes at the meeting of 30 Apr 2025. On say-on-pay, 9 of 31 voted against management (29.0%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Opus Genetics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for Opus Genetics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Opus Genetics, Inc. with a meeting date within three days of 30 Apr 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.